Severity and Breadth of Issue

It is normal for humans to experience mild anxiety. But when feelings of anxiety prevent one from fully engaging in life, one has an “anxiety disorder.”1 Thirty million Americans suffer from anxiety disorders.2 The cost to the economy in lost productivity is estimated at $40 billion annually.3

Impact

Anxiety disorders number around seven and receive less attention than depression and are less diagnosed by primary care doctors. More women than men suffer from anxiety disorders and they tend to run in families. These disorders can be profoundly disabling.4

Conventional Therapeutics

The most common treatment used by conventional medicine is the prescribing of SSRIs such as Prozac, sertraline, Zoloft, etc.5 Anti-seizure medication is often prescribed. All of these medications can have serious side effects. Deep brain stimulation (DBT)6 and Cognitive Behavior Therapy (CBT)7 are used by some physicians.

Other Therapeutics

Many patients seek alternative remedies in herbs, vitamins, nutritional supplements, and in acupuncture and homeopathy. They also turn to various “energy modalities” for relief. These treatments are not regulated by the FDA. While there have been some studies on the efficacy of alternative remedies, they are minimal and inconclusive.8

Solution

The Trivedi EffectR introduced by Mahendra Kumar Trivedi is an authentic groundbreaking science that can eradicate an anxiety disorder at its root.9 The Life Force energy of the Trivedi EffectR connects its subject to the limitless intelligence of the universe and restores the individual’s natural wellbeing at the cellular level.10

The Life Force energy of the Trivedi EffectR calms the body and brain so that the spirit can thrive. Agitation, nervousness, fear which are at the root of pathological anxiety disappear.

_______________________________

References:

Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M, et al. One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry. 1988

Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, David- son JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999; 60:427-35.

Stein MB, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Pyne JM, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 2005; 43:1164-70.

Koen N, Stein DJ. Pharmacotherapy of anxiety disorders: A critical review. Dialogues Clin Neurosci. 2011;13(4):423–437.

Abelson JL, Curtis GC, Sagher O, et al. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry. 2005;57(5):510–516.

Foa EB, Franklin ME, Moser J. Context in the clinic: How well do cognitive–behavioral therapies and medications work in combination? Biol Psychiatry. 2002;52 (10):987–997.